NDC 71335-2326 – Cevimeline Hydrochloride

Cevimeline Hydrochloride 30 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC71335-2326

Product details

Brand name
Cevimeline Hydrochloride
Generic name
Cevimeline Hydrochloride
Labeler
Bryant Ranch Prepack
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA216682
Marketed since
April 6, 2023
Listing expires
December 31, 2027
Pharmacologic class
Cholinergic Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Cevimeline hydrochloride →

Package NDC codes (3)

Package NDCDescriptionSince
71335-2326-130 CAPSULE in 1 BOTTLE, PLASTIC (71335-2326-1)Jan 8, 2024
71335-2326-260 CAPSULE in 1 BOTTLE, PLASTIC (71335-2326-2)Jan 8, 2024
71335-2326-390 CAPSULE in 1 BOTTLE, PLASTIC (71335-2326-3)Jan 8, 2024

Other Cevimeline hydrochloride products